Abstract
Recombinant protein vaccines against SARS-CoV-2
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/s1473-3099(21)00227-9
Journal: The Lancet Infectious Diseases | Publication Date: Apr 19, 2021 |
Citations: 8 | License type: NO-CC CODE |
Recombinant protein vaccines against SARS-CoV-2
Join us for a 30 min session where you can share your feedback and ask us any queries you have